These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30237176)

  • 1. Alternatives to specific uric acid lowering treatment in gout in patients with cardiovascular disease.
    Ashcroft JA
    BMJ; 2018 Sep; 362():k3895. PubMed ID: 30237176
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new application for well-known pharmaceutics--losartan and fenofibrate as potential remedies against gout?].
    Saar J; Kirch W
    Dtsch Med Wochenschr; 2014 Mar; 139(12):608. PubMed ID: 24619720
    [No Abstract]   [Full Text] [Related]  

  • 3. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
    Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
    Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GOUT AND HYPERTENSION].
    Belovol AN; Knyazkova II; Miroshnykova IA
    Lik Sprava; 2015; (1-2):32-8. PubMed ID: 26118024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
    Ivanovic B; Tadic M
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the atherosclerotic process in clinical practice. A new look at established agents.
    Deanfield JE
    Atherosclerosis; 2002 Dec; 165(2):189-90. PubMed ID: 12417268
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopidogrel Hypersensitivity: Overview of the Problem.
    Savage MP; Fischman DL
    Curr Vasc Pharmacol; 2019; 17(2):108-109. PubMed ID: 30124153
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of angiotensin II type 1 receptor blocker/calcium channel blocker combination therapy for hypertension: focus on a single-pill fixed-dose combination of valsartan and amlodipine.
    Miura S; Saku K
    J Int Med Res; 2012; 40(1):1-9. PubMed ID: 22429340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.
    Ogihara T; Nakao K; Fukui T; Fukiyama K; Ueshima K; Oba K; Sato T; Saruta T;
    Hypertension; 2008 Feb; 51(2):393-8. PubMed ID: 18172059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overuse of Statins in Older Adults.
    Lazris A; Roth AR
    Am Fam Physician; 2019 Dec; 100(12):742-743. PubMed ID: 31845782
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose-dependent atorvastatin associated with angioedema.
    Al-Qaaneh AM; Obaid WT; Al-Mohammadi OS; Al-Qaaneh AM; Rabaan AA; Mustafa SM
    Int J Clin Pharmacol Ther; 2022 Feb; 60(2):106-110. PubMed ID: 34779391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
    Delgado-Montero A; Zamorano JL
    Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W
    MMW Fortschr Med; 2004 Jul; 146(27-28):41. PubMed ID: 15526662
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible negative effect of co-administered amlodipine and atorvastatin on semen volume and spermatozoa in men.
    Cai T; Mondaini N; Mazzoli S; Bartoletti R
    J Pharm Pharmacol; 2008 Nov; 60(11):1431-2. PubMed ID: 18957162
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
    Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
    Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid reduction: a new paradigm in the management of cardiovascular risk?
    Dawson J; Quinn T; Walters M
    Curr Med Chem; 2007; 14(17):1879-86. PubMed ID: 17627523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
    Frishman WH; Zuckerman AL
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.